SARS COV-2 Controls Delivery

Notice ID:

N6809622Q0009

Department/Ind. Agency:

DEPT OF DEFENSE

Sub-tier:

DEPT OF DEFENSE

Sub Command:

U S NAVAL HOSPITAL GUAM

Office:

U S NAVAL HOSPITAL GUAM

All Dates/Times are:

(utc-05:00) eastern standard time, new york, usa

Updated Published Date:

(utc-05:00) eastern standard time, new york, usa

Original Published Date:

0000-00-00 00:00:00

Original Response Date:

dec 02, 2021 08:00 pm est

Inactive Policy:

manual

Original Inactive Date:

dec 02, 2021

Initiative:

• None***--***

Product Service Code:

6505 - drugs and biologicals

NAICS Code:

325413 - in-vitro diagnostic substance manufacturing

Original Set Aside:

Combined Synopsis/Solicitation SARS COV-2 Controls This is a combined synopsis/solicitation for commercial items prepared per the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations/offers are being requested. A written solicitation will not be issued. Solicitation N6809622Q0009-- is being issued as a Request for Quotation (RFQ). The commercial items under solicitation N6809622Q0009 will be acquired via competition to the maximum extent practicable. Solicitation N6809622Q0009-- and the incorporated provisions and clauses are those in effect through the Federal Acquisition Circulation 2022-01.

PSC 490 BOX 7717

FPO , AP 96538-1600

USA

Primary Point of Contacts:

Eddie L. "Franc" Franklin